期刊文献+

肺癌并静脉血栓栓塞症的危险因素分析 被引量:5

Analysis of risk factors of venous thromboembolism in lung cancer patients
下载PDF
导出
摘要 目的总结我院38例肺癌合并静脉血栓患者的临床资料,探讨其发生的危险因素。方法对2010年4月至2015年7月本院38例肺癌合并静脉血栓患者(血栓组)与同期76例不存在静脉血栓的肺癌患者(非血栓组)的临床资料进行回顾性病例-对照分析。单因素分析后,对有可能有意义的因素进行多因素Logistic回归分析,查找肺癌合并静脉血栓的危险因素。结果单因素分析显示腺癌、ⅢB-Ⅳ期、D二聚体增高、中心静脉置管、CEA增高是发生静脉血栓的危险因素(P〈0.05)。多因素回归分析显示腺癌、ⅢB~Ⅳ期、D二聚体增高是肺癌发生静脉血栓的独立危险因素(P〈0.05)。结论肺腺癌、肿瘤晚期、D二聚体增高是肺癌合并静脉血栓的高危因素。 Objective To summarize the clinical data of 38 cases of lung cancer with venous thromboembolism (VTE), and to analyze risk factors of lung cancer with VTE. Methods We reviewed the clinical data of patients with lung cancer who were diagnosed with VTE (38 cases) and without VTE (76 cases) from April 2010 to July 2015. Univariate analysis was conducted to determine the possible associated variables. Multivariate Logistic regression analysis was applied to explore risk factors of lung cancer with VTE. Results Univariate analysis showed adenoearcinoma, stageⅢ B- Ⅳ, increased D Dimmer, central venous indwelling catheter, increased CEA were risk factors of lung cancer with VTE (P〈0.05). Multivariate Logistic regression analysis showed adenocarcinoma, stage Ⅲ B- Ⅳ, increased D Dimmer were independent risk factors of lung cancer with VTE (P〈0.05). Conclusion Adenocarcinoma, stage Ⅲ B- Ⅳ, increased D Dimmer were important risk factors of lung cancer with VTE.
出处 《国际医药卫生导报》 2017年第4期502-504,共3页 International Medicine and Health Guidance News
关键词 肺癌 静脉血栓栓塞 危险因素 恶性肿瘤 Lung cancer Venous thromboembolism Risk factor Cancer
  • 相关文献

参考文献4

二级参考文献49

  • 1Kearon C,Kahn SR,Agnelli G,et al.Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).Chest.2008 Jun; 133(6 Suppl):454S-545S; Erratum in 2008,134:892.
  • 2Jaff MR,McMurtry MS,Archer SL,et al.Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis,and chronic thromboembolic pulmonary hypertension.Circulation,2011,123:1788-1830.
  • 3Iles S. Clot Burden and Comorbidity in Natural History of Untreated Pulmonary Thromboembolism:Autopsy Data in the Trial by Barritt And Jordan.Chest,2003,124:1178-1179.
  • 4Stein PD,Hull RD,Ghali WA,et al.Tracking the uptake of evidence:two decades of hospital practice trends for diagnosing deep vein thrombosis and pulmonary embolism.Arch Intern Med,2003,163:1213-1219.
  • 5Stein PD,Hull RD,Pineo G. Strategy that includes serial noninvasive leg tests for diagnosis of thromboembolic disease in patients with suspected acute pulmonary embolism based on data from PIOPED. Prospective Investigation of Pulmonary Embolism Diagnosis.Arch Intern Med,1995,155:2101-2104.
  • 6Büller HR,Ten Cate-Hoek AJ,Hoes AW,et al. AMUSE (Amsterdam Maastricht Utrecht Study on thromboEmbolism)Investigators.Safely ruling out deep venous thrombosis in primary care.Ann Intern Med,2009,150:229-235.
  • 7Décousus H,Bertoletti L,Frappé P,et al.Recent findings in the epidemiology, diagnosis and treatment of superficial-vein thrombosis.Thromb Res,2011,127 Suppl 3:S81-S85.
  • 8Decousus H,Prandoni P,Mismetti P,et al.Fondaparinux in the treatment of lower-limb superficial-vein thrombosis.N Engl J Med,2010,363:1222-1232.
  • 9Iqbal Z,Cohen M.Emerging antithrombotic agents:what does the intensivist need to know? Curr Opin Crit Care,2010,16:419-425.
  • 10EINSTEIN Investigators,Bauersachs R,Berkowitz SD,et al.Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med,2010,363:2499.

共引文献83

同被引文献42

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部